{"abstract": "Novartis International agreed to buy Fougera Pharmaceuticals, a maker of generic skin care medicine, in a move that would make it the biggest manufacturer in the field.", "web_url": "https://dealbook.nytimes.com/2012/05/02/novartis-to-buy-fougera-pharmaceuticals-for-1-5-billion/", "snippet": "Novartis International agreed to buy Fougera Pharmaceuticals, a maker of generic skin care medicine, in a move that would make it the biggest manufacturer in the field.", "lead_paragraph": "Novartis International agreed on Wednesday to buy Fougera Pharmaceuticals, a maker of generic skin care medicine, for $1.525 billion in cash. The move would make the company the biggest manufacturer in the field.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Novartis to Buy Fougera Pharmaceuticals for $1.5 Billion", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Fougera Pharmaceuticals Inc", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Novartis AG", "rank": 4, "major": "N"}], "pub_date": "2012-05-02T21:17:53+0000", "document_type": "article", "news_desk": "", "section_name": "Business Day", "byline": {"original": "By Michael J. de la Merced", "person": [{"firstname": "Michael", "middlename": "J.", "lastname": "de la Merced", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/925d79f6-410c-5540-82f5-c6a1f719c166", "word_count": 246, "uri": "nyt://article/925d79f6-410c-5540-82f5-c6a1f719c166"}